AKTX

Akari Therapeutics

6 hedge funds and large institutions have $269K invested in Akari Therapeutics in 2015 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
-4
Holders Change %
-40%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
1
Reduced
1
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
CAM
1
Cormorant Asset Management
Massachusetts
$218K -$10.2K -67 -4%
VKH
2
Virtu KCG Holdings
New York
$26K +$26K +168 New
Citadel Advisors
3
Citadel Advisors
Florida
$22K +$22K +143 New
Citigroup
4
Citigroup
New York
$1K +$500 +2 +100%
Wells Fargo
5
Wells Fargo
California
$1K +$1K +6 New
UBS Group
6
UBS Group
Switzerland
$1K +$1K +7 New
Franklin Resources
7
Franklin Resources
California
-$3.37M -3,509 Closed
BBA
8
Baker Bros. Advisors
New York
-$3.24M -3,369 Closed
SM
9
Sabby Management
Florida
-$2.59K -2,694 Closed
BC
10
Broadfin Capital
New York
-$2.26M -2,354 Closed
SCM
11
Sio Capital Management
New York
-$881K -918 Closed
DCM
12
DAFNA Capital Management
California
-$211K -220 Closed
HighTower Advisors
13
HighTower Advisors
Illinois
-$66K -69 Closed
TRCT
14
Tower Research Capital (TRC)
New York
-$3K -3 Closed